Effects of early surfactant treatment persisting for one week after lung transplantation in rats

被引:24
作者
Erasmus, ME
Hofstede, GJH
Petersen, AH
Haagsman, HP
Oetomo, SB
Prop, J
机构
[1] UNIV GRONINGEN HOSP,DEPT CARDIOPULM SURG,DIV RES,NL-9700 RB GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,DEPT PEDIAT,DIV RES,NL-9700 RB GRONINGEN,NETHERLANDS
[3] UNIV UTRECHT,VET BIOCHEM LAB,NL-3508 TD UTRECHT,NETHERLANDS
关键词
D O I
10.1164/ajrccm.156.2.9607005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We investigated whether pulmonary surfactant in rat lung transplants recovered during the first week post-transplantation, along with symptoms of the reimplantation response, and whether this recovery was affected by early surfactant treatment. The severity of pulmonary injury was varied by transplanting left lungs with 6-h and 20-h ischemia (n = 12 and 19, respectively). Half of the transplants were treated by instillation of surfactant before reperfusion. Lungs from sham operated, and normal rats (n = 4 and 5, respectively) served as controls. The pulmonary injury severely impaired lung transplant function; 10 of the worst affected animals died. After 1 wk, symptoms of reimplantation response and properties of pulmonary surfactant were assessed. If untreated, the reimplantation response had almost resolved in the 6-h but not in the 20-h ischemia group; pulmonary surfactant, however, continued to be deficient in both ischemia groups (low amounts of surfactant phospholipids and surfactant protein A [SP-A]). Surfactant treatment improved the recovery from injury in the 20-h ischemia group resulting in normal lung function and amounts of surfactant phospholipids. Amounts of SP-A were not improved by surfactant treatment. In conclusion, early surfactant treatment enhances recovery from transplantation injury and is persistently beneficial for pulmonary surfactant in lung transplants.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 29 条
[1]   TUMOR NECROSIS FACTOR-ALPHA-INDUCED INHIBITION OF PHOSPHATIDYLCHOLINE SYNTHESIS BY HUMAN TYPE-II PNEUMOCYTES IS PARTIALLY MEDIATED BY PROSTAGLANDINS [J].
ARIASDIAZ, J ;
VARA, E ;
GARCIA, C ;
BALIBREA, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :244-250
[2]  
BHAGWANA.SG, 1972, LANCET, V2, P66
[3]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[4]   LUNG OXIDANT INJURY IN A MODEL OF LUNG STORAGE AND EXTENDED REPERFUSION [J].
CHRISTIE, NA ;
SMITH, DE ;
DECAMPOS, KN ;
SLUTSKY, AS ;
PATTERSON, GA ;
TANSWELL, AK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (04) :1032-1037
[5]   BIOLOGY OF LUNG PRESERVATION FOR TRANSPLANTATION [J].
COOPER, JD ;
VREIM, CE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (03) :803-807
[6]   PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT [J].
ENHORNING, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) :198-203
[7]  
ERASMUS ME, 1994, J HEART LUNG TRANSPL, V13, P791
[8]  
ERASMUS ME, 1996, AM J RESP CRIT CARE, V153, P666
[9]   PHOSPHOLIPID-SYNTHESIS IN ISOLATED ALVEOLAR TYPE-II CELLS EXPOSED INVITRO TO PARAQUAT AND HYPEROXIA [J].
HAAGSMAN, HP ;
SCHUURMANS, EAJM ;
BATENBURG, JJ ;
VANGOLDE, LMG .
BIOCHEMICAL JOURNAL, 1987, 245 (01) :119-126
[10]  
HAMM H, 1995, AM J RESP CRIT CARE, V151, pA92